Abstract
There are no data on the efficacy of secondary prophylaxis against Pneumocystis pneumonia after solid organ transplantation. Therefore, we investigated the rate of recurrence of Pneumocystis pneumonia after solid organ transplantation in a retrospective cohort study. Between 2005 and 2011, a total of 41 recipients recovered from Pneumocystis pneumonia. Of these, 22 (53.7%) received secondary prophylaxis. None of the 41 recipients experienced recurrence of Pneumocystis pneumonia during the follow-up, regardless of secondary prophylaxis.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use*
-
Antibiotic Prophylaxis*
-
Female
-
Humans
-
Male
-
Middle Aged
-
Organ Transplantation / adverse effects
-
Pneumocystis carinii / drug effects
-
Pneumocystis carinii / growth & development
-
Pneumonia, Pneumocystis / etiology
-
Pneumonia, Pneumocystis / microbiology
-
Pneumonia, Pneumocystis / prevention & control*
-
Retrospective Studies
-
Secondary Prevention*
-
Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*
Substances
-
Anti-Bacterial Agents
-
Trimethoprim, Sulfamethoxazole Drug Combination